Skip to content

Comparison of Vortic Catch V Basket Catheter and Ordinary Basket Catheter for the Removal of Bile Duct Stones

Randomized Trial of the Removal Ability With Vortic Catch V Basket Catheter Versus Ordinary Basket Catheter for Bile Duct Stones

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05363345
Enrollment
100
Registered
2022-05-05
Start date
2022-02-02
Completion date
2026-12-31
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Randomized Study

Brief summary

Investigators will perform randomized trial of the removal ability with Vortic Catch V basket catheter versus ordinary basket catheter for bile duct stones (≧ 10 mm).

Interventions

DEVICEbile duct stone removal

Common bile duct stones (≧ 10 mm) are removed by using Vortic Catch V basket catheter or ordinary basket catheter following endoscopic papillary large balloon dilation.

Sponsors

Akira Horiuchi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with suspected of having, or known to have, common bile duct stones (≧ 10 mm) * endoscopic papillary balloon dilation (EPLBD) was performed.

Exclusion criteria

* septic shock * coagulopathy (international normalized ratio 1.3, partial thromboplastin time greater than twice that of control), * \<platelet count 50,000 / L * suspected or confirmed malignancy

Design outcomes

Primary

MeasureTime frameDescription
Percentage of stones clearedProcedure timePercentage of stones cleared is evaluated after the completion of procedure.

Secondary

MeasureTime frameDescription
Total procedural timeProcedure timeTotal procedure time is measured.
the number of adverse eventsProcedure timeAdverse events are evaluated after the completion of procedure.
the numbers of morbidities and mortality30 daysMorbidities and mortality is evaluated within 30 days after the completion of procedure.

Countries

Japan

Contacts

CONTACTAkira Horiuchi, MD
horiuchi.akira@sihp.jp09021684311

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026